Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India

Diabetes Care

Volumn 21, Issue 11, 1998, Pages 1819-1823

  Mohan, Viswanathan ^a   Deepa, Raj ^a   Haranath, Sai Prashanth ^a   Premalatha, Gopal ^a   Rema, Mohan ^a   Sastry, Nadiminti Ganapathi ^a   Enas, Enas A ^b  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b CADI Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; INDIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

BIOLOGICAL MARKERS; CHOLESTEROL; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; INDIA; LIPOPROTEIN(A); PREVALENCE; RISK FACTORS; TRIGLYCERIDES;

EID: 0031784894     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.11.1819     Document Type: Article

References (41)

1. Mckeigue PM, Miller GJ, Marmot MG: Coronary artery disease in South Asian overseas: a review. J Clin Epidemiol 41:597-598, 1989
2. Balarajan R: Ethnic difference in mortality from ischaemic heart disease in England and Wales. Br Med J 302:560-564, 1991
3. Beckles GLA, Miller GJ, Kirkwood BR, Alexis SD, Carson DC, Byam NTA: High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet 1:1298-1301, 1986
4. Chadha S, Radhakrishnan S, Ramachandran K, Kaul U, Gopinath N: Epidemiological study of coronary heart disease in urban population of Delhi. Indian J Med Res 92:424-430, 1990
5. Raman Kutty V, Balakrishnan KG, Jayasree AK, Thomas J: Prevalence of coronary heart disease in the rural population of Thiru- vananthapuram district, Kerala India. Int J Cardiol 39:59-70, 1993
6. Gupta R, Prakash H, Majumdar S, Sharma S, Gupta VP: Prevalence of coronary heart disease and coronary risk factors in an urban population of Rajasthan. Indian Heart J 47:331-338, 1995
7. Hughes LO, Raval U, Raftery EB: First myocardial infarction in Asian and White men. Br Med J 298:1345-1350, 1989
8. Litter WA, Lawrence RE: Acute myocardial infarction in Asians and Whites in Birmingham. Br Med J 290:1472, 1985
9. Ramachandran A, Jali MV, Mohan V, Snehalatha C, Viswanathan M: High prevalence of diabetes in an urban population in South India. Br Med J 297:587-590, 1988
10. Mckeigue PM, Shah B, Marmot MG: Relation of central obesity insulin resistance with high diabetes prevalence and cardiovascular risk in south Asia. Lancet 336:383-386, 1991
11. Mohan V, Sharp PS, Cloke HR, Burrin JM, Schemer B, Kohner EM: Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (non insulin dependent) diabetic patients and control subjects. Diabetologia 29:235-237, 1987
12. Mckeigue PM, Marmot MG, Court YDS, Cottier DE, Rahman S, Riemersman RA: Diabetes, hypertension, and cardiac risk factors in Bangladeshis in East London. Br Heart J 60:390-396, 1985
13. Sharp PS, Mohan V, Levy JC, Mather HM, Kohner EM: Insulin resistance in patients of Asian Indian and European origin with non insulin dependent diabetic. Horm Metab Res 18:84-85, 1987
14. Laws A, Jeppesen JL, Maheux PC, Schaaf P, Chen YD-I, Reaven GM: Resistance to insulin stimulated glucose uptake and dyslipidemia in Asian Indians. Arterioscler Thromb 14:917-922, 1994
15. Forouchi N, McKeigue P: How far can risk factors account for excess coronary mortality in South Asians? (Abstract). Can J Cardiol 13:47B, 1997
16. Berg K: Lp(a) Lipoprotein: an overview. In Lipoprotein (a). Scanu AM, Ed. San Diego, CA, Academic, 1990, p, 1-23
17. Utermann G: The mysteries of lipoprotein (a). Science 246:904-910, 1989
18. Scanu AM, Lawn RM, Berg K: Lipoprotein (a) and atherosclerosis. Ann Intern Med 115:209-218, 1991
19. Heam JA, DeMaio SJ Jr, Roubin GS, Hammarstrom M, Sgoutas D: Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease. Am J Cardiol 66:1176-1180, 1990
20. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM Jr: Association of levels of lipoprotein Lp(a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography Circulation 74:758-765, 1986
21. Frick MH, Dahlen G, Berg K, Valle M, Hekali P: Serum lipids in angiographically assessed coronary atherosclerosis. Chest 73:62-65, 1973
22. Ridker PM, Hennekens CH, Stampfer MJ: A prospective study of lipoprotein (a) and risk of myocardial infarction. JAMA 270:2195-2199, 1993
23. Haffner SM: Lipoprotein (a) and diabetes, Diabetes Care 16:835-840, 1993
24. Jenkins AJ, Steele JS, Junus ED, Santamaria JD, Best JD: Plasma apolipoprotein (a) is increased in type 2 (non insulin dependent) diabetic patient with microalbuminuria. Diabetologia 35:1055-1059, 1992
25. Haffner SM, Moss SEM, Klein BEK, Klein R: Lack of association between Lp(a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Metabolism 41:194-197, 1992
26. Niskanen L, Mykkanen L, Karonen SL, Uusitupa M: Apoprotein (a) levels in relation to coronary heart disease and risk factors in type II (non insulin dependent) diabetes. Cardiovasc Risk Factors 13:205-210, 1993
27. O'Brien T, Nguyen TT, Harrison JM, Bailey KR, Dyck PJ, Kottke BA: Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non insulin dependent diabetes mellitus. Mayo Clin Proc 69:430-435, 1994
28. Guyton JR, Dahlen GH, Patsch M, Kautz JA, Gotto AM Jr: Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B. Arteriosclerosis 5:265-272, 1985
29. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org, 1985 (Tech. Rep. Ser., no. 727)
30. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). Arch Intern Med 153:154-183, 1993
31. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
32. Low PS, Heng CK, Saha N, Tay JSH: Racial variation of cord plasma lipoprotein (a) levels in relation to coronary risk level: a study in three ethnic groups in Singapore. Pediatr Res 40:718-722, 1996
33. Hughes K, Aw TC, Kuperan P, Choo M: Central obesity, insulin resistance, syndrome X, lipoprotein (a) and cardiovascular in Indians, Malays and Chinese in Singapore. J Epidemiol Community Health 51:394-399, 1997
34. Anand SS, Enas EA, Pogue J, Haffner S, Pearson T, Yusuf S: Elevated lipoprotein (a) levels in South Asians in North America, Metabolism 47:182-184, 1998
35. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PWF, Schaefer EJ, Castelli WP: Elevated plasma lipoprotein (a) and coronary heart disease in men aged 55 years and younger: a prospective study JAMA 276:544-548, 1996
36. Wild SH, Fortmann SP, Marcovina SM: A prospective case control study of lipoprotein (a) levels and Apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants. Arterioscler Thromb Vasc Biol 17:239-245, 1997
37. Cobbaert C, Jukema JW, Zwinderman AH, Withagen AJAM, Lindemans J, Bruschke AVG: Modulation of lipoprotein (a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Am Coll Cardiol 30:1491-1499, 1997
38. Schriewer H, Assmann G, Sandkamp M: The relationship of lipoprotein (a) Lp(a) to risk factors of coronary heart disease: initial results of prospective epidemiological study on company employees in Westfalia. J Clin Chem Clin Biochem 22:591-596, 1984
39. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Seidel D: The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis dependence of serum LDL levels. Atherosclerosis 62:249-257, 1986
40. Enas FA, Dhawan J, Petkar S: Coronary artery disease in Asian Indians: lessons learnt and the role of lipoprotein (a). Indian Heart J 49:25-34, 1997
41. Enas EA, Mehta J: Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention and therapy. Clin Cardiol 18:131-135, 1995